Exchangeable IOLs top recent ophthalmic business news
The most popular ophthalmic business items so far this year include a discussion on exchangeable IOLs and the announcement of a research agreement.
Check out some recent ophthalmic business news items below:
Exchangeable IOLs may be option for presbyopia management
Easily exchangeable IOLs and more advanced accommodating IOLs may be on the horizon for presbyopia management, according to speakers on the clinical panel at the virtual Ophthalmology Innovation Summit Presbyopia Innovation Showcase. Read more.
BLOG: What new ophthalmologists will know that we did not
Standards for care in keratoconus have been changing rapidly. As today’s residents and fellows prepare to enter practice, they will have a completely different perspective on this disease than ophthalmologists who are more experienced. Read more.
Verana Health, Janssen enter research agreement
Verana Health and Janssen have entered into a research collaboration agreement focusing on ophthalmology and urology. Read more.
Ocumension makes $15.7 million equity investment in EyePoint
EyePoint Pharmaceuticals received a $15.7 million equity investment from Ocumension Therapeutics. Read more.
VIDEO: Glaukos discusses recent study results with iDose TR, iStent infinite
In this video perspective, Joseph Gilliam, chief financial officer and senior vice president of corporate development at Glaukos, discusses the latest news on the iDose TR and iStent infinite. Watch here.